Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Ekso Bionics Holdings (EKSO) Debt to Equity (2016 - 2025)

Historic Debt to Equity for Ekso Bionics Holdings (EKSO) over the last 13 years, with Q3 2025 value amounting to $0.31.

  • Ekso Bionics Holdings' Debt to Equity rose 1251.1% to $0.31 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.31, marking a year-over-year increase of 1251.1%. This contributed to the annual value of $0.3 for FY2024, which is 2087.4% down from last year.
  • As of Q3 2025, Ekso Bionics Holdings' Debt to Equity stood at $0.31, which was up 1251.1% from $0.31 recorded in Q2 2025.
  • Over the past 5 years, Ekso Bionics Holdings' Debt to Equity peaked at $0.38 during Q4 2023, and registered a low of $0.05 during Q2 2021.
  • Moreover, its 5-year median value for Debt to Equity was $0.23 (2023), whereas its average is $0.21.
  • Its Debt to Equity has fluctuated over the past 5 years, first crashed by 9227.87% in 2021, then surged by 19482.77% in 2023.
  • Quarter analysis of 5 years shows Ekso Bionics Holdings' Debt to Equity stood at $0.05 in 2021, then surged by 176.5% to $0.15 in 2022, then skyrocketed by 158.88% to $0.38 in 2023, then dropped by 20.87% to $0.3 in 2024, then grew by 2.43% to $0.31 in 2025.
  • Its Debt to Equity was $0.31 in Q3 2025, compared to $0.31 in Q2 2025 and $0.28 in Q1 2025.